P0 and myelin basic protein-like immunoreactivities following ligation of the sciatic nerve in the rat

Neurochemical Research

Volumn 27, Issue 11, 2002, Pages 1293-1303

  Setton Avruj, C Patricia ^a,b   Aquino, Jorge B ^b   Goedelman, Carolina J ^a   Soto, Eduardo F ^a   Villar, Marcelo J ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

Myelin; Nerve injury; Schwann cells; Wallerian degeneration

Indexed keywords

GLYCOPROTEIN; MYELIN; MYELIN BASIC PROTEIN; PROTEIN ZERO; UNCLASSIFIED DRUG; MYELIN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISSECTION; ELECTROPHORESIS; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE DEGENERATION; NERVE INJURY; NERVE LIGATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SCIATIC NERVE; SURVIVAL TIME; ANIMAL; INJURY; METABOLISM; WISTAR RAT;

ANIMALIA; WALLERIA;

ANIMALS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOHISTOCHEMISTRY; MYELIN BASIC PROTEINS; MYELIN P0 PROTEIN; RATS; RATS, WISTAR; SCIATIC NERVE;

EID: 0036877595     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021663414122     Document Type: Article

References (42)

1. Fernández-Valle, C., Bunge, R. P., and Bartlett Bunge, M. 1995. Schwann cells degrade myelin and proliferate in the absence of macrophages. Evidence from in vitro studies of Wallerian degeneration. J. Neurocytol. 24:667-679.
2. Shen, Z. L., Lassner, F., Bader, A., Becker, M., Walter, G. F., and Berger, A. 2000. Cellular activity of resident macrophages during Wallerian degeneration. Microsurgery 20:255-261.
3. Baichwal, R. R., Bigbee, W., and De Vries, G. H. 1988. Macrophage-mediated myelin-related mitogenic factor for cultured Schwann cells. Proc. Natl. Acad. Sci. USA 85:1701-1705.
4. Stoll, G. and Müller, H. W. 1999. Nerve injury, axonal degeneration and neural regeneration: Basic insights. Brain Pathol. 9:313-325.
5. Hirata, K., Mitoma, H., Ueno, N., He, J. W., and Kawabuchi, M. 1999. Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve. J. Neurocytol. 28:685-695.
6. Baichwal, R. R. and De Vries, G. H. 1989. A mitogen for Schwann cells is derived from myelin basic protein. Biochem. Biophys. Res. Commun. 164(2):883-888.
7. Tzeng, S. F., Deibler, G. E., Neuberger, T. J., and De Vries, G. H. 1995. Two mitogenic regions of myelin basic protein interact with different receptors to induce Schwann cell proliferation in a cAMP dependent process. J. Neurosci. Res. 42:758-767.
8. Tzeng, S. F., Deibler, G. E., and De Vries, G. H. 1999. Myelin basic protein and myelin basic protein peptides induce the proliferation of Schwann cells via ganglioside GM1 and the FGF receptor. Neurochem. Res. 24(2):255-260.
9. Garbay, B., Heape, A. M., Sargueil, F., and Cassagne, C. 2000. Myelin synthesis in the peripheral nervous system. Prog. Neurobiol. 61:267-304.
10. LeBlanc, A. C. and Poduslo, J. F. 1990. Axonal modulation of myelin gene expression in the peripheral nerve. J. Neurosci. Res. 26:317-326.
11. Hirata, K., He, J. W., Kuraoka, A., Omata, Y., Hirata, M., Islam, A. T., Noguchi, M., and Kawabuchi, M. 2000. Heme oxygenase1 (HSP-32) is induced in myelin-phagocytosing schwann cells of injured sciatic nerves in the rat. Eur. J. Neurosci. 12(11):4147-4152.
12. Liu, H.-M., Yang, L. H., and Yang, Y. J. 1995. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J. Neuropathol. Exp. Neurol. 54:487-496.
13. Gupta, S. K., Pringle, J., Poduslo, J. F., and Mezei, C. 1993. Induction of myelin genes during peripheral nerve remyelination requires a continuous signal from the ingrowing axon. J. Neurosci. Res. 34:14-23.
14. LeBlanc, A. C., Poduslo, J. F., and Mezel, C. 1987. Gene expression in the presence or absence of myelin assembly. Mol. Brain Res. 2:57-67.
15. Scheidt, P., Waehneldt, T. V., Beuche, W., and Friede, R. L. 1986. Changes of myelin proteins during Wallerian degeneration in situ and in millipore diffusion chambers preventing active phagocytosis. Brain Res. 379:380-384.
16. Shu, S., Ju, G., and Fan, L. 1988. The glucose oxidase method in peroxidase histochemistry of the nervous system. Neurosci. Lett. 85:169-171.
17. Andreoni, G., Angeretti, N., Lucca, E., and Fortoni, G. 1997. Densitometric quantification of neuronal viability by computerized image analysis. Exp. Neurol. 148:281-287.
18. 0. J. Neurosci. Res. 46:531-539.
19. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
20. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
21. Barbarese, E., Braun, P. E., and Carson, J. H. 1977. Identification of prelarge and presmall basic proteins in mouse myelin and their structural relationship to large and small basic proteins. Proc. Natl. Acad. Sci. USA 74:3360-3364.
22. Gilbert, W. R., Garwood, M. M., Agrawal, D., Schmidt, R. E., and Agrawal, H. C. 1982. Immunoblot identification of phosphorylated basic proteins of rat and rabbit CNS and PNS myelin: Evidence for four phosphorylated basic proteins and P2 in rat PNS myelin. Neurochem. Res. 7:1495-1506.
23. Greenfield, S., Brostoff, S. W., and Hogan, E. L. 1980. Characterization of the basic proteins from rodent peripheral nervous system myelin. J. Neurochem. 34:453-455.
24. Greenfield, S., Weise, M. J., Gantt, G., Hogan, E. L., and Brostoff, S. W. 1982. Basic proteins of rodent peripheral nerve myelin: Immunochemical identification of the 21.5K, 18.5K, 17K, 14K and P2 proteins. J. Neurochem. 39:1278-1282.
25. Weise, M. J., Greenfield, S., Brostoff, S. W., and Hogan, E. L. 1983. Protein composition of PNS myelin: Developmental comparison of control and Quaking mice. J. Neurochem. 41:448-453.
26. Greenfield, S., Brostoff, S., Eylar, E. H., and Morell, P. 1973. Protein composition of myelin of the peripheral nervous system. J. Neurochem. 20:1207-1216.
27. Wiggins, R. C., Benjamins, J. A., and Morell, P. 1975. Appearance of myelin proteins in rat sciatic nerve during development. Brain Res. 89:99-106.
28. Smith, M. E. and Curtis, B. M. 1979. Frog sciatic nerve myelin: A chemical characterization. J. Neurochem. 33:447-452.
29. Brück, W. 1997. The role of macrophages in Wallerian degeneration. Brain Pathol. 7:741-752.
30. Stoll, G., Griffin, J. W., Li, C. Y., and Trapp, B. D. 1989. Wallerian degeneration in the peripheral nervous system: Participation of both Schwann cells and macrophages in myelin degradation. J. Neurocytol. 18:671-683.
31. Martínez, A. M. B. and Canavarro, S. 2000. Early myelin breakdown following sural nerve crush: A freeze-fracture study. Braz. J. Med. Biol. Res. 33:1477-1482.
32. Patsalos, P. N., Bell, M. E., and Wiggins, R. C. 1980. Pattern of myelin breakdown during Wallerian degeneration: Reversal of the order of assembly. J. Cell Biol. 87:1-5.
33. Koltzenburg, M., Wall, P. D., and McMahon, S. B. 1999. Does the right side know what the left is doing? Trends Neurosci. 22:112-127.
34. Avelino, A. M., Hart, D., Dailey, A. T., MacKinnon, M., Ellegala, D., and Kliot, M. 1995. Differential macrophage responses in the peripheral and central nervous system during Wallerian degeneration of axons. Exp. Neurol. 136:183-198.
35. Venezie, R. D., Toews, A. D., and Morell, P. 1995. Macrophage recruitment in different models of nerve injury: Lysozyme as a marker for active phagocytosis. J. Neurosci. Res. 40(1):99-107.
36. Gillen, C., Gleichmann, M., Spreyer, P., and Müller, H. W. 1995. Differentially expressed genes after peripheral nerve injury. J. Neurosci. Res. 42:159-171.
37. Wee Yong, V., Power, C., Forsyth, P., and Edwards, D. R. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. 2:502-511.
38. La Fleur, M., Underwood, J. L., Rappolee, D. A., and Werb, Z. 1996. Basement membrane and repair of injury to peripheral nerve: Defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184:2311-2326.
39. Matyszak, M. K. and Perry, V. H. 1996. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases. J. Neuroimmunol. 69:141-149.
40. Chandler, S. et al. 1997. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview. J. Neuroimmunol. 72:155-161.
41. Proost, P., Van Damme, J., and Opdenakker, G. 1993. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem. Biophys. Res. Commun. 192:1175-1181.
42. De Leon, M., Welcher, A. A., Suter, U., and Shooter, E. M. 1991. Identification of transcriptionally regulated genes after sciatic nerve injury. J. Neurosci. Res. 29:437-448.